CORMEDIX INC.
CRMD
 Delayed - 05/17 04:00:01 pm |
|
| 3.82USD | +5.82% |
Upcoming events on CORMEDIX INC.
| 08/16/22 | Interim 2022 Earnings Release (Projected) |
| 11/10/22 | Q3 2022 Earnings Release (Projected) |
| 03/16/23 | FY 2022 Earnings Release (Projected) |
| 05/11/23 | Q1 2023 Earnings Release (Projected) |
Past events on CORMEDIX INC.
| 05/12/22 | 04:30pm | Q1 2022 Earnings Call |
| 05/12/22 | Q1 2022 Earnings Release |
| 04/12/22 | 11:00am | Needham Virtual Healthcare Conference |
| 03/29/22 | 04:30pm | FY 2021 Earnings Call |
Upcoming sector events for CORMEDIX INC.
| 05/31/22 | DOTTIKON ES HOLDING AG : FY 2022 Earnings Release (Projected) |
| 08/04/22 | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : Interim 2022 Earnings Call |
| 08/04/22 | KYOWA KIRIN CO., LTD. : Interim 2022 Earnings Release |
| 08/04/22 | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : Interim 2022 Earnings Release |
Past sector events for CORMEDIX INC.
| 05/12/22 | 08:00am | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : Q1 2022 Earnings Call |
| 05/12/22 | 01:00am | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : Q1 2022 Earnings Release |
| 05/11/22 | SK BIOPHARMACEUTICALS CO., LTD. : Q1 2022 Earnings Release (Projected) |
| 05/10/22 | 02:00am | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. : Annual General Meeting |
Annual results
| Fiscal Period : December | 2021 | 2022 | ||||||||||||
| Sales M $ |
Released Forecast Spread | 0,19 0,12 54% | 0,64 | |||||||||||
| Operating income (EBITDA) M $ |
Released Forecast Spread | | ||||||||||||
| Operating profit (EBIT) M $ |
Released Forecast Spread | -29,4 -30,1 2,2% | -36,4 | |||||||||||
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -29,5 -30,1 2,1% | -36,5 | |||||||||||
| Net income M $ |
Released Forecast Spread | -28,2 -30,3 6,8% | -36,5 | |||||||||||
| EPS $ |
Released Forecast Spread | -0,75 -0,80 5,9% | -0,87 | |||||||||||
| Announcement Date | 03/29/2022 | - | ||||||||||||
| ||||||||||||||
Previous year
Quarterly / Semiannualy publications
| Fiscal Period : December | 2022 Q1 | 2022 Q2 | ||||||||||||||||||||||||
| Sales M $ |
Released Forecast Spread | 0,01 0,02 -54% | | |||||||||||||||||||||||
| Operating income (EBITDA) M $ |
Released Forecast Spread | | ||||||||||||||||||||||||
| Operating profit (EBIT) M $ |
Released Forecast Spread | -7,03 -8,42 16% | -8,00 | |||||||||||||||||||||||
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -7,03 -8,42 16% | -8,00 | |||||||||||||||||||||||
| Net income M $ |
Released Forecast Spread | -7,03 -8,42 16% | -8,00 | |||||||||||||||||||||||
| EPS $ |
Released Forecast Spread | -0,18 -0,22 18% | -0,21 | |||||||||||||||||||||||
| Announcement Date | 05/12/2022 | - | ||||||||||||||||||||||||
| ||||||||||||||||||||||||||
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
